Therapeutic Areas

IBSA at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Paris, April 2019

IBSA gladly announces the participation at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO), Paris, April 4th-7th 2019 https://www.wco-iof-esceo.org/. IBSA is attending the congress with a Satellite Symposium on the main product of the company in the field of OA treatment, our pharmaceutical-grade chondroitin sulfate (Friday, April 5th 2019, 17.00 - 18.30, Auditorium B): “Differences in the efficacy of various Chondroitin Sulfate preparations: Facts or fantasy?”. Please find here the full programme.